Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FE 999301 in Active Inflammatory Bowel Disease
DRKS00010101Phase 2Completed
- Sponsor
- Universitätsklinikum Schleswig-Holstein
- Start
- Jul 2016
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of olamkicept in Crohn's disease and autoimmune colitis, sponsored by Universitätsklinikum Schleswig-Holstein. Started Jul 2016; status: completed.
02
Drugs
olamkicept
03
Conditions
Crohn's diseaseautoimmune colitis
Beyond the preview
Go deeper on DRKS00010101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00010101.